• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of different lymph node staging systems in prognosis of gastric cancer: a bi-institutional study from Hungary.不同淋巴结分期系统对胃癌预后的比较:一项来自匈牙利的双机构研究
Chin J Cancer Res. 2017 Aug;29(4):323-332. doi: 10.21147/j.issn.1000-9604.2017.04.05.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer.内镜超声检查(EUS)对原发性胃癌术前局部区域分期的诊断准确性。
Cochrane Database Syst Rev. 2015 Feb 6;2015(2):CD009944. doi: 10.1002/14651858.CD009944.pub2.
4
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
5
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
6
Lymphadenectomy or sentinel node biopsy for the management of endometrial cancer.用于子宫内膜癌治疗的淋巴结切除术或前哨淋巴结活检术。
Cochrane Database Syst Rev. 2025 Jun 10;6(6):CD015786. doi: 10.1002/14651858.CD015786.pub2.
7
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.
8
Lymphadenectomy for the management of endometrial cancer.用于子宫内膜癌治疗的淋巴结切除术。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD007585. doi: 10.1002/14651858.CD007585.pub4.
9
[Relationship between primary tumor lymph node indicators and prognosis and treatment response in colorectal cancer patients with lung metastases].[结直肠癌肺转移患者原发肿瘤淋巴结指标与预后及治疗反应的关系]
Zhonghua Yi Xue Za Zhi. 2025 Aug 5;105(29):2491-2499. doi: 10.3760/cma.j.cn112137-20250324-00724.
10
Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer.前哨淋巴结评估在诊断外阴癌腹股沟淋巴结受累中的应用
Cochrane Database Syst Rev. 2014 Jun 27;2014(6):CD010409. doi: 10.1002/14651858.CD010409.pub2.

引用本文的文献

1
Evaluation of three lymph node staging systems for prognostic prediction in gastric cancer: A systematic review and meta-analysis.三种淋巴结分期系统对胃癌预后预测的评估:一项系统评价和荟萃分析
World J Gastrointest Oncol. 2025 Mar 15;17(3):98103. doi: 10.4251/wjgo.v17.i3.98103.
2
Advances in molecular imaging and targeted therapeutics for lymph node metastasis in cancer: a comprehensive review.癌症淋巴结转移的分子成像与靶向治疗进展:综述
J Nanobiotechnology. 2024 Dec 19;22(1):783. doi: 10.1186/s12951-024-02940-4.
3
The Role of Alternative Lymph Node Classification Systems in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Superiority of a LODDS Scheme Over N Category in Pancreatic NEN (pNEN).替代淋巴结分类系统在胃肠胰神经内分泌肿瘤(GEP-NEN)中的作用:LODDS 方案优于胰腺神经内分泌肿瘤(pNEN)的 N 分类。
Horm Metab Res. 2023 Jul;55(7):452-461. doi: 10.1055/a-2102-7694. Epub 2023 Jul 10.
4
Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis.淋巴结阳性对数比作为胃癌新型预后预测因子的系统评价和荟萃分析。
BMC Cancer. 2023 Jun 8;23(1):523. doi: 10.1186/s12885-023-10805-6.
5
Establishment and validation of a prognostic nomogram for postoperative patients with gastric cardia adenocarcinoma: A study based on the Surveillance, Epidemiology, and End Results database and a Chinese cohort.基于 Surveillance, Epidemiology, and End Results 数据库和中国队列的胃贲门腺癌术后患者预后列线图的建立和验证。
Cancer Med. 2023 Jun;12(12):13111-13122. doi: 10.1002/cam4.5994. Epub 2023 May 3.
6
N, LNR or LODDS: Which Is the Most Appropriate Lymph Node Classification Scheme for Patients with Radically Resected Pancreatic Cancer?N、LNR还是LODDS:哪种是根治性切除胰腺癌患者最合适的淋巴结分类方案?
Cancers (Basel). 2022 Apr 6;14(7):1834. doi: 10.3390/cancers14071834.
7
Does lymph node ratio (metastasis/total lymph node count) affect survival and prognosis in gastric cancer?淋巴结转移率(转移/总淋巴结计数)是否影响胃癌的生存和预后?
Saudi Med J. 2022 Feb;43(2):139-145. doi: 10.15537/smj.2022.43.2.20210464.
8
Prognostic Performance of Alternative Lymph Node Classification Systems for Patients with Medullary Thyroid Cancer: A Single Center Cohort Study.替代淋巴结分类系统对甲状腺髓样癌患者预后的预测性能:一项单中心队列研究。
Ann Surg Oncol. 2022 Apr;29(4):2561-2569. doi: 10.1245/s10434-021-11134-3. Epub 2021 Dec 10.
9
Prognostic Discrimination of Alternative Lymph Node Classification Systems for Patients with Radically Resected Non-Metastatic Colorectal Cancer: A Cohort Study from a Single Tertiary Referral Center.根治性切除的非转移性结直肠癌患者替代淋巴结分类系统的预后判别:来自单一三级转诊中心的队列研究
Cancers (Basel). 2021 Aug 2;13(15):3898. doi: 10.3390/cancers13153898.
10
Impact of retrieved lymph node count on short-term complications in patients with gastric cancer.胃癌患者获取的淋巴结数量对短期并发症的影响。
World J Surg Oncol. 2020 Aug 24;18(1):224. doi: 10.1186/s12957-020-02000-9.

本文引用的文献

1
[Role of a computer program in gastric cancer surgery - beyond the evidence].计算机程序在胃癌手术中的作用——超越现有证据
Magy Seb. 2017 Mar;70(1):48-55. doi: 10.1556/1046.70.2017.1.7.
2
Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center.基于淋巴结比率的分期系统在2575例胃癌患者预后预测中的优越性:大型单中心验证分析
Oncotarget. 2016 Aug 9;7(32):51069-51081. doi: 10.18632/oncotarget.9714.
3
Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy.三种不同淋巴结分期系统对胃癌患者D2淋巴结清扫术后生存的预后价值
Tumour Biol. 2016 Aug;37(8):11105-13. doi: 10.1007/s13277-015-4191-7. Epub 2016 Feb 24.
4
Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project.胃癌TNM分类新分期分组的提议:国际胃癌协会分期项目
Gastric Cancer. 2017 Mar;20(2):217-225. doi: 10.1007/s10120-016-0601-9. Epub 2016 Feb 20.
5
Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients.转移淋巴结比率成功预测西方胃癌患者的预后。
Surg Oncol. 2015 Jun;24(2):84-8. doi: 10.1016/j.suronc.2015.03.001. Epub 2015 Mar 24.
6
Superiority of the ratio between negative and positive lymph nodes for predicting the prognosis for patients with gastric cancer.阴性与阳性淋巴结比例在预测胃癌患者预后方面的优越性。
Ann Surg Oncol. 2015 Apr;22(4):1258-66. doi: 10.1245/s10434-014-4121-8. Epub 2014 Oct 16.
7
Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base.可切除胃癌中淋巴结分期不足的影响:一项使用国家癌症数据库的当代分析
Cancer. 2014 Sep 15;120(18):2855-65. doi: 10.1002/cncr.28780. Epub 2014 May 22.
8
Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma?阳性淋巴结的对数优势比(LODDS):它们在胃腺癌预后评估中起什么作用?
J Gastrointest Surg. 2014 Jul;18(7):1254-60. doi: 10.1007/s11605-014-2539-8. Epub 2014 May 20.
9
Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.随机对照临床试验比较胃癌行 D1 或 D2 胃切除术的生存情况。
Br J Surg. 2014 Jan;101(2):23-31. doi: 10.1002/bjs.9345.
10
Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience.胃癌淋巴结检出数及检出率的预后影响:美国单中心经验。
J Gastrointest Surg. 2013 Dec;17(12):2059-66. doi: 10.1007/s11605-013-2380-5. Epub 2013 Oct 16.

不同淋巴结分期系统对胃癌预后的比较:一项来自匈牙利的双机构研究

Comparison of different lymph node staging systems in prognosis of gastric cancer: a bi-institutional study from Hungary.

作者信息

Tóth Dezső, Bíró Adrienn, Varga Zsolt, Török Miklós, Árkosy Péter

机构信息

Department of General Surgery, Kenézy Gyula Teaching Hospital, Debrecen 4031, Hungary.

出版信息

Chin J Cancer Res. 2017 Aug;29(4):323-332. doi: 10.21147/j.issn.1000-9604.2017.04.05.

DOI:10.21147/j.issn.1000-9604.2017.04.05
PMID:28947864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5592820/
Abstract

OBJECTIVE

The Union for International Cancer Control (UICC) Node (N) classification is the most common used staging method for the prognosis of gastric cancer. It demands adequate, at least 16 lymph nodes (LNs) to be dissected; therefore different staging systems were invented.

METHODS

Between March 2005 and March 2010, 164 patients were evaluated at the Department of General Surgery in the Kenézy Gyula Hospital and at the Department of General, Thoracic and Vascular Surgery in the Kaposi Mór Hospital. The 6th, 7th and 8th UICC N-staging systems, the number of examined LNs, the number of harvested negative LNs, the metastatic lymph node ratio (MLR) and the log odds of positive LNs (LODDS) were determined to measure their 5-year survival rates and to compare them to each other.

RESULTS

The overall 5-year survival rate for all patients was 55.5% with a median overall survival time of 102 months. The tumor stage, gender, UICC N-stages, MLR and the LODDS were significant prognostic factors for the 5-year survival with univariate analysis. The 6th UICC N-stage did not follow the adequate risk in comparing N2 . N0 and N3 . N0 with multivariate investigation. Comparison of performances of the residual N classifications proved that the LODDS system was first in the prediction of prognosis during the evaluation of all patients and in cases with less than 16 harvested LNs. The MLR gave the best prognostic prediction when adequate (more than or equal to 16) lymphadenectomy was performed.

CONCLUSIONS

We suggest the application of LODDS system routinely in western patients and the usage of MLR classification in cases with extended lymphadenectomy.

摘要

目的

国际癌症控制联盟(UICC)的淋巴结(N)分类是胃癌预后最常用的分期方法。它要求至少切除16枚淋巴结;因此发明了不同的分期系统。

方法

2005年3月至2010年3月期间,对凯内齐·久洛医院普通外科以及卡波西·莫尔医院普通、胸科和血管外科的164例患者进行了评估。确定了第6版、第7版和第8版UICC N分期系统、检查的淋巴结数量、切除的阴性淋巴结数量、转移淋巴结比率(MLR)和阳性淋巴结对数优势比(LODDS),以测量其5年生存率并相互比较。

结果

所有患者的总体5年生存率为55.5%,中位总生存时间为102个月。单因素分析显示,肿瘤分期、性别、UICC N分期、MLR和LODDS是5年生存的重要预后因素。多因素研究比较N2.N0和N3.N0时,第6版UICC N分期未遵循适当风险。残余N分类性能比较证明,在评估所有患者以及切除的淋巴结少于16枚的病例中,LODDS系统在预后预测方面排名第一。当进行充分(大于或等于16枚)淋巴结清扫时,MLR给出了最佳预后预测。

结论

我们建议在西方患者中常规应用LODDS系统,在进行扩大淋巴结清扫的病例中使用MLR分类。